Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Soleil Boughton currently holds 171,829 shares of Hims & Hers Health, Inc. (HIMS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Soleil Boughton has been a net seller of HIMS stock. They have purchased $0 and sold $9.8M worth of shares.
Soleil Boughton's most recent insider trade was on Dec 15, 2025, when they sold 22,817 shares at $36.25 per share.
Soleil Boughton serves as Executive at Hims & Hers Health, Inc. (HIMS). They have executed 146 insider transactions totaling $9.8M over their tenure at the company.
Soleil Boughton holds the position of Executive at Hims & Hers Health, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Soleil Boughton has shown a selling trading pattern, with $0 in total purchases and $9.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Soleil Boughton was on Sep 15, 2025, when they sold $1.2M worth of HIMS shares. This transaction involved 22,829 shares at $53.96 per share.
Soleil Boughton currently owns 171,829 shares of Hims & Hers Health, Inc. (HIMS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Soleil Boughton's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Soleil Boughton has 146 Form 4 filings on record as an insider at Hims & Hers Health, Inc..
Set alerts for Soleil Boughton and 40,000+ other insiders.